Retinal Vascular Imaging
Department of Vitreoretina

Retinal Vein Occlusion

Managing the "stroke" of the eye. Through precision Anti-VEGF therapy and vascular mapping, Prasan Nethralaya treats the hemorrhaging and edema caused by retinal vein blockages to reclaim your visual clarity.

Understanding the Vascular Blockage

The retina relies on a sophisticated "plumbing" system: arteries deliver oxygen-rich blood, while veins carry deoxygenated blood away. Retinal Vein Occlusion (RVO) occurs when one of these veins becomes blocked or compressed.

Imagine a drain in your home becoming clogged while the faucet is still running. The pressure builds up until the pipes leak or burst. In the eye, this results in blood and fluid spilling directly into the retinal layers. This causes sudden, painless vision loss. Depending on where the clog occurs, it is classified as either a Central Retinal Vein Occlusion (CRVO), affecting the entire retina, or a Branch Retinal Veinal Occlusion (BRVO), affecting only a specific segment.

Clinical Indicators of RVO

Unlike many eye conditions, RVO is almost always sudden and involves only one eye. Seek evaluation if you notice:

  • Sudden, painless blurring of vision in one eye.
  • A dark shadow or "grayness" over part or all of your sight.
  • Significant distortion (straight lines appearing wavy).
  • Sudden onset of "floaters" or dark spots.

The Diagnostic & Treatment Protocol

RVO management focuses on two goals: reducing the swelling in the macula (macular edema) and preventing the growth of dangerous new blood vessels (neovascularization).

1. Advanced Diagnostic Imaging

We use Optical Coherence Tomography (OCT) to measure the exact thickness of the macula and detect fluid pockets. Additionally, Fundus Fluorescein Angiography (FFA) is often performed to map the blood flow and identify areas of the retina that are "ischemic" (starved for oxygen), which helps predict the risk of future complications.

2. Intravitreal Anti-VEGF Injections

The primary treatment for the vision-robbing swelling associated with RVO is Anti-VEGF therapy. These medications (like Lucentis or Eylea) are injected into the eye to block the chemical signal that causes vessels to leak. By "drying up" the macula, vision often improves significantly. Most patients require a series of monthly injections initially, followed by a maintenance schedule as the eye stabilizes.

3. Retinal Laser Photocoagulation

If the blockage has caused large areas of the retina to lose their blood supply, the eye may try to grow abnormal new vessels in response. These vessels are fragile and can lead to severe bleeding or glaucoma. In these cases, Dr. Jaideep Sharma utilizes targeted Laser Photocoagulation to treat the oxygen-starved tissue, permanently stopping the growth of these dangerous vessels.

4. Managing Systemic Risk Factors

Because RVO is a vascular event, it is often a "wake-up call" for your overall health. We work closely with your physician to ensure that underlying conditions like hypertension, high cholesterol, and diabetes are aggressively managed to prevent a recurrence in the other eye or more serious systemic events.

Prognosis & Visual Recovery

Visual recovery after an RVO varies from patient to patient. While some regain near-normal vision with timely injections, others may have permanent blind spots if the retina was deprived of oxygen for too long. The single most important factor in a successful outcome is the speed of intervention. Early treatment of macular edema before permanent structural changes occur is the key to reclaiming your sight.

Clinical Director
Dr. Jaideep Sharma

Dr. Jaideep Sharma

Vitreoretina Expert

Mastering advanced medical retina management and precision vascular intervention for RVO patients in Jaipur.

View Credentials ↗

Request a Consult

Sudden vision loss requires an immediate OCT scan. Secure your evaluation today.

Patient
Questions.

Clinical clarity regarding vascular blockages, injection protocols, and long-term visual prognosis.

Vision recovery depends on the severity of the blockage and how quickly treatment begins. Many patients experience significant improvement with Anti-VEGF injections that reduce macular swelling. However, some permanent vision loss may occur if the retina was deprived of oxygen (ischemia) for a prolonged period.

CRVO (Central Retinal Vein Occlusion) involves the main vein of the retina, affecting vision across the entire eye. BRVO (Branch Retinal Vein Occlusion) involves a smaller branch vein, typically affecting only a specific sector or quadrant of your vision. BRVO usually has a better prognosis.

The primary risk factors are high blood pressure, diabetes, and high cholesterol. In these conditions, hardened arteries can press against and compress the adjacent veins at points where they cross, leading to a blockage or blood clot formation.

Not necessarily. While many patients require a series of injections over 1-2 years to manage the fluid leakage, the frequency often decreases significantly over time as the eye stabilizes, the original blockage clears, or the eye develops "collateral" drainage channels.

While RVO itself is localized to the eye, the underlying vascular conditions that cause it (like hypertension) also increase the risk of systemic stroke or heart disease. An RVO diagnosis is a critical signal to review and optimize your overall cardiovascular health with your primary physician.

Stop the Leakage.

Sudden vision loss from RVO is a clinical emergency. Early intervention with Anti-VEGF therapy is the only way to prevent permanent macular scarring.

Book Retina Evaluation